文献速递脑血管病外科小儿神经外科与脑积水

儿童脑动静脉畸形的复发:一项长期随访研究

Recurrence of brain arteriovenous malformations in pediatric patients: a long-term follow-up study.
PubMed 文献 · Acta Neurochir (Wien) · 2023-05-04

本研究对42例儿童期接受治疗且经DSA确认完全闭塞的脑动静脉畸形患者进行长期随访DSA复查,41例纳入分析,中位随访年龄33.8岁,检出2例散发性AVM复发和1例遗传性出血性毛细血管扩张症(HHT)相关AVM复发,散发性AVM复发率为4.9%,纳入HHT后为7.1%,作者据此推荐影像学随访。

要点

  • 儿童期经DSA确认完全闭塞的AVM仍可在成年后复发,散发性AVM复发率4.9%,纳入HHT后为7.1%。
  • 所有复发AVM最初均曾出血并接受显微手术治疗。
  • 作者结论认为儿童和青少年AVM患者易出现复发,推荐进行影像学随访。

核心结论

  • 儿童和青少年患者即使经血管造影确认AVM完全闭塞,仍易发生AVM复发,因此推荐进行影像学随访。

研究设计与样本

  • 本研究为长期随访研究,对2021至2022年间按新方案安排控制性DSA血管造影的、治疗时年龄小于21岁且治疗至少5年前完成的AVM患者进行分析,新方案仅对当时年龄小于50岁的患者提供血管造影。
  • 共42例患者参与晚期DSA控制检查,排除1例诊断为HHT的患者后,41例纳入本分析。
  • 所有患者在原发治疗后AVM完全根除均已通过DSA确认。

主要发现

  • 患者因AVM治疗入院时的中位年龄为14.6岁(IQR 12-19,范围7-21岁),晚期随访DSA时的中位年龄为33.8岁(IQR 29.8-38.6,范围19.4-47.9岁)。
  • 检出2例散发性AVM复发和1例HHT患者AVM复发。
  • 散发性AVM复发率为4.9%,若纳入HHT-AVM则为7.1%。
  • 所有复发AVM最初均曾出血并接受显微手术治疗。
  • 散发性AVM复发的患者整个成年期均吸烟。

关键数值与推荐

  • 散发性AVM复发率为4.9%,纳入HHT-AVM后复发率为7.1%。

临床怎么用

  • 作者结论认为儿童和青少年AVM患者易发生复发,推荐进行影像学随访。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previously thought to be congenital, AVMs have shown evidence of de-novo formation and continued growth, thus shifting thoughts on their pathophysiology. Pediatric AVM patients have been reported to be more prone to develop AVM recurrence after a seemingly complete cure. Therefore, we assessed the risk of AVM treated in childhood to recur in adulthood after a long-term follow-up in our own cohort. METHODS: Control DS-angiography was arranged during 2021-2022 as part of a new protocol for all AVM patients who were under 21 years of age at the time of their treatment and in whom the treatment had occurred at least five years earlier. Angiography was offered only to patients under 50 years of age at the time of the new protocol. The complete eradication of AVM after the primary treatment had been originally confirmed with DSA in every patient. RESULTS: A total of 42 patients participated in the late DSA control, and 41 of them were included in this analysis after excluding the patient diagnosed with HHT. The median age at the time of admission for AVM treatment was 14.6 (IQR 12-19, range 7-21 years) years. The median age at the time of the late follow-up DSA was 33.8 years (IQR 29.8-38.6, range 19.4-47.9 years). Two recurrent sporadic AVMs and one recurrent AVM in a patient with hereditary hemorrhagic telangiectasia (HHT) were detected. The recurrence rate was 4.9% for sporadic AVMs and 7.1% if HHT-AVM was included. All the recurrent AVMs had originally bled and been treated microsurgically. The patients with sporadic AVM recurrence had been smoking their whole adult lives. CONCLUSIONS: Pediatric and adolescent patients are prone to develop recurrent AVMs, even after complete AVM obliteration verified by angiography. Therefore, imaging follow-up is recommended.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Oulasvirta E, Koroknay-Pál P, Numminen J, et al. Recurrence of brain arteriovenous malformations in pediatric patients: a long-term follow-up study. Acta Neurochir (Wien). 2023. PMID: 37140647. doi:10.1007/s00701-023-05612-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。